Articles On Bio-Gene Technology (ASX:BGT)

The ASX finished in the green by just 0.03%. Today’s gain was spurred by a 1.34% rally in tech shares as well as a rally in Crown (ASX:CWN) shares in the wash-up of the Victorian government’s royal commission. Despite the report finding the...

The ASX is off to a positive start this week, putting its total gains over the past three weeks up to about 3.6%. The ASX 200 closed 0.34% higher – at 7,441 points. Spurring today’s gains was energy with a 2.64% gain while resources and uti...

Bio-Gene Technology (BGT) executes a commercial deal with Evergreen Garden Care The partnership gives Evergreen exclusive rights to BGT’s natural tech and data to develop new insecticides for markets in Europe, the UK, Australia and New Ze...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Tech stocks pull back on rate hike concerns Concerns about a possible rate hike pushed US tech stocks down on Friday. US Fed Chairman Jerome Powell said the central bank was monitoring price pressures, and would adapt its policies according...

It’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher than yesterday, closing at 7,362 which marked a 3 week high but is still 3.5% above the all time high reached in mid-August. Travel stocks gai...

Aussie shares rebounded today following rises in the US and Europe overnight, after having fallen for the previous two days. The ASX 200 regained 0.78%, with all 11 sectors in the green except for Industrials and IT. Healthcare and financia...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Despite the rodent plague that threatened Australia’s $50 billion agricultural industry, we are poised for a second consecutive bumper harvest. According to the latest forecasts from Rabobank, and based on the average seasonal conditions fr...

Summary TheASX 200 is trading lower by 68.40 points or 0.96% to 7028.60, led by a fall in energy, financial and realty stocks. 10 out of 11 sectors traded in red, while energy and utilities were the worst performers, falling over 2% ea...

Summary Bio-Gene revealed interim results from a stored grain trial, indicating favourable efficacy data after a 3-month interim review. The identification of a lead Flavocide combination took place in September 2020. Flavocide can bu...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

In June, ASX-listed companies of all sizes continued to raise capital but the small-cap sector was particularly busy. Stocks with market capitalisations of under $100m at the time of the deal raised $274m in the last month. This is triple M...

Special Report: New study finds Bio-Gene insecticide is non-toxic to water-based plants and animals. Bio-Gene Technology (ASX: BGT) has gone swimming after preliminary aquatic eco-toxicity studies found the active constituent contained in...

TechTalk is Stockhead’s video series featuring a roundtable of industry experts discussing a new investing topic each week. In this edition, technology analyst and host Tim Knapton focuses on the agritech sector. Populating the TechTalk exp...

A quick wrap of the key winners and losers on Tuesday, May 26. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

Our summary of Bio-Gene Technology Ltd's recent announcement What's happened? Bio-Gene Technology Limited (ASX:BGT) have announced the successful completion of its stage one Flavocide research program with BASF and GRDC for stored grain pes...

Just over 3 months since seeing its insecticide products pass US trials, agriculture technology development company Bio-Gene Technology (ASX: BGT) has unveiled a partnership with US company Clarke Mosquito Control to develop its Flavocide a...

COVID-19 may seem the only bug worth seeking to squash right now but there are at least two other battles that haven’t witnessed a ceasefire. One prominant group of bugs are the so-called “super bugs” — bacteria which as its name suggests c...

Special Report: Insecticide developer Bio-Gene is lining up deals, with the latest to see its products used in public health mosquito control across the Americas.  Agtech development company Bio-Gene Technology’s (ASX:BGT) novel insecticid...

Contrary to what many fearful Australians may have felt over the last month, the country does not have a food supply problem. Indeed, this is why professional investors are using the market crisis caused by the COVID-19 pandemic to buy into...

Ag-tech company Bio-Gene Technology (BGT), has reported on its second quarter for the 2020 financial year Last month, the company made a significant breakthrough which confirmed Flavocide can control the mosquito species that carry the Ma...

Cancer is a crowded market, pot has sleep and pain issues covered — or so they say — and companies dip in and out of respiratory diseases all the time. But there are a few ASX-listed stocks that are tackling health issues that still rate as...

Special Report: The company’s research program with the world-leading entomology unit at Purdue University in the US has resulted in a unique solution to a global problem. Ag-tech development Bio-Gene (ASX:BGT) updated the market with a key...

Insecticide maker Bio-Gene (ASX:BGT) says a trial is proving one of its products is lethal against a particularly difficult to kill mosquito. The Anopheles gambiae mosquito carries malaria and is increasingly resistant to more commonly used...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The results of collective US trials by Australian ag-tech development company Bio-Gene Technology (ASX: BGT) have confirmed the natural compound product Flavocide can control the Anopheles gambiae mosquito species which carries malaria and...

Shares in Queensland-based agricultural biotech Terragen (ASX:TGH) fell flat on its first day on the ASX, initially ticking up to 26c before falling back to 21c. The company launched a $20m IPO, offering shares at 25c, in November, with a p...

Agriculture technology (AgTech) company Bio-Gene Technology (ASX: BGT) has reported results from a recent grain storage program and said its Flavocide product was able to meet key industry standards. Results confirmed that Flavocide continu...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Bio-Gene Technology (ASX: BGT) has secured a partnership with world leading chemical company BASF, with the duo planning to develop Bio-Gene’s Flavocide technology for use is stored grain pest control across Australia. The Queensland Govern...

The healthcare industry in Australia has witnessed rapid developments over the past several years. Thanks to the same, today Australia boasts one of the best healthcare systems in the world. The publicly listed healthcare companies in Austr...